Intuit
INTU
297.24
+7.43
+2.56%
Intuit
US · INTU
#260 by market cap
Listed 1970
297.24
+7.43
+2.56%
Live - 5344 symbols - heartbeat 45s ago
· 2026-10-08 07:00
Pre-market
297.50
+0.55%
After-hours
297.16
-0.03%
Overnight
295.22
-0.22%
- Market cap
- 79.43B
- P/E (TTM)i
- 18.06
- P/Bi
- 4.18
- EPSi
- 16.46
- Div yieldi
- 1.61%
- 52W posi
- 11%
Reader sentiment
Are you bullish or bearish on INTU?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.71, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +13.90% YoY
Margins
- Gross margin
- 80.17%
- Operating margin
- 28.80%
- Net margin
- 21.29%
Key ratios & quality
- Enterprise valuei
- 79.99B
- PEG ratioi
- 0.75
- Altman Z-Scorei
- 4.71
PEG uses trailing P/E against the 3-year net income growth rate (24.19%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.78B | 7.68B | 9.63B | 12.73B | 14.37B | 16.29B | 18.83B | 21.45B |
| Gross profit | 5.62B | 6.30B | 7.95B | 10.32B | 11.23B | 12.82B | 14.98B | 17.20B |
| Selling & admin expenses | 2.52B | 2.72B | 3.60B | 5.00B | 5.06B | 5.73B | 6.64B | 7.16B |
| Research & development | 1.23B | 1.39B | 1.68B | 2.35B | 2.54B | 2.75B | 2.93B | 3.38B |
| Operating profit | 1.86B | 2.18B | 2.53B | 2.56B | 3.14B | 3.85B | 4.94B | 6.18B |
| Pretax profit | 1.88B | 2.20B | 2.56B | 2.54B | 2.99B | 3.55B | 4.83B | 6.02B |
| Tax | 324.00M | 372.00M | 494.00M | 476.00M | 605.00M | 587.00M | 965.00M | 1.45B |
| Net profit | 1.56B | 1.83B | 2.06B | 2.07B | 2.38B | 2.96B | 3.87B | 4.57B |
| Basic EPS | 6 | 7 | 8 | 7 | 8 | 11 | 14 | 17 |
| Diluted EPS | 5.89 | 6.92 | 7.56 | 7.28 | 8.42 | 10.43 | 13.67 | 16.46 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 7.75B | 3.83B | 3.89B | 4.65B | 8.56B | 4.35B |
| Gross profit | 6.56B | 2.94B | 3.00B | 3.61B | 7.18B | 3.40B |
| Selling & admin expenses | 2.01B | 1.68B | 1.50B | 1.80B | 2.20B | 1.66B |
| Research & development | 707.00M | 801.00M | 843.00M | 836.00M | 840.00M | 857.00M |
| Operating profit | 3.72B | 340.00M | 534.00M | 855.00M | 4.02B | 768.00M |
| Pretax profit | 3.68B | 366.00M | 561.00M | 869.00M | 4.05B | 540.00M |
| Tax | 864.00M | -15.00M | 115.00M | 176.00M | 983.00M | 177.00M |
| Net profit | 2.82B | 381.00M | 446.00M | 693.00M | 3.06B | 363.00M |
| Basic EPS | 10 | 1 | 2 | 2 | 11 | 1 |
| Diluted EPS | 10.02 | 1.35 | 1.59 | 2.48 | 11.09 | 1.34 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.59B | 7.98B | 5.16B | 5.05B | 5.56B | 9.68B | 14.11B | 15.31B |
| Cash & ST investments | 2.74B | 7.05B | 3.87B | 3.28B | 3.66B | 4.07B | 4.55B | 7.20B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 6.28B | 10.93B | 15.52B | 27.73B | 27.78B | 32.13B | 36.96B | 36.79B |
| Total current liabilities | 1.97B | 3.53B | 2.66B | 3.63B | 3.79B | 7.49B | 10.37B | 10.16B |
| Short-term debt | 50.00M | 1.38B | 66.00M | 583.00M | 89.00M | 570.00M | 69.00M | 1.33B |
| Long-term debt | 386.00M | 2.03B | 2.03B | 6.42B | 6.12B | 5.54B | 5.97B | 6.42B |
| Total liabilities | 2,534,000,000.00 | 5,825,000,000.00 | 5,647,000,000.00 | 11,293,000,000.00 | 10,511,000,000.00 | 13,696,000,000.00 | 17,248,000,000.00 | 17,794,000,000.00 |
| Total equity | 3.75B | 5.11B | 9.87B | 16.44B | 17.27B | 18.44B | 19.71B | 18.99B |
| Retained earnings | 9.62B | 10.89B | 12.30B | 13.58B | 15.07B | 16.99B | 19.67B | 19.05B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 13.97B | 14.11B | 10.42B | 11.70B | 17.84B | 15.31B |
| Cash & ST investments | 6.17B | 4.55B | 3.70B | 2.98B | 8.44B | 7.20B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 36.59B | 36.96B | 33.19B | 34.28B | 39.33B | 36.79B |
| Total current liabilities | 9.65B | 10.37B | 7.52B | 8.84B | 12.28B | 10.16B |
| Short-term debt | 567.00M | 69.00M | 827.00M | 831.00M | 833.00M | 1.33B |
| Long-term debt | 5.91B | 5.97B | 5.39B | 5.41B | 5.41B | 6.42B |
| Total liabilities | 16,468,000,000.00 | 17,248,000,000.00 | 13,869,000,000.00 | 15,227,000,000.00 | 18,701,000,000.00 | 17,794,000,000.00 |
| Total equity | 20.13B | 19.71B | 19.32B | 19.06B | 20.63B | 18.99B |
| Retained earnings | 19.59B | 19.67B | 19.77B | 20.12B | 22.85B | 19.05B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.32B | 2.41B | 3.25B | 3.89B | 5.05B | 4.88B | 6.21B | 8.84B |
| Depreciation & amortization | 225.00M | 218.00M | 363.00M | 746.00M | 806.00M | 789.00M | 809.00M | 846.00M |
| Free cash flow | 2.17B | 2.28B | 3.13B | 3.66B | 4.79B | 4.63B | 6.08B | 8.62B |
| Dividends paid | -501.00M | -561.00M | -646.00M | -774.00M | -889.00M | -1.03B | -1.19B | -1.35B |
| Stock buybacks / issuance | -556.00M | -323.00M | -1.01B | -1.86B | -1.97B | -1.99B | -2.77B | -5.41B |
| Ending cash balance | 2.35B | 6.70B | 2.82B | 3.00B | 2.85B | 7.10B | 9.48B | 9.22B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 4.40B | 381.00M | 637.00M | 1.57B | 5.30B | 1.33B |
| Depreciation & amortization | 201.00M | 208.00M | 209.00M | 209.00M | 210.00M | 218.00M |
| Free cash flow | 4.36B | 356.00M | 599.00M | 1.52B | 5.24B | 1.26B |
| Dividends paid | -292.00M | -301.00M | -341.00M | -341.00M | -333.00M | -332.00M |
| Stock buybacks / issuance | -752.00M | -746.00M | -854.00M | -933.00M | -1.55B | -2.07B |
| Ending cash balance | 10.18B | 9.48B | 6.94B | 6.78B | 11.91B | 9.22B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 51.02 | 41.24 | 27.54 | 15.71 | 14.14 | 16.60 | 20.29 | 23.60 |
| ROA %i | 27.17 | 21.22 | 15.59 | 9.55 | 8.59 | 9.89 | 11.20 | 12.38 |
| ROIC %i | 43.89 | 27.93 | 19.34 | 11.45 | 10.42 | 12.43 | 15.29 | 17.20 |
| 5-year avg ROE %i | 51.81 | 57.36 | 51.66 | 39.13 | 29.21 | 23.05 | 18.85 | 18.07 |
| EBIT margin %i | 27.95 | 28.81 | 26.83 | 20.61 | 22.53 | 23.29 | 26.98 | 29.25 |
| FCF / sales %i | 31.97 | 29.65 | 32.44 | 28.76 | 33.31 | 28.46 | 32.30 | 40.18 |
| Current ratioi | 1.83 | 2.26 | 1.94 | 1.39 | 1.47 | 1.29 | 1.36 | 1.51 |
| Quick ratioi | 1.69 | 2.17 | 1.87 | 1.31 | 1.37 | 1.24 | 1.31 | 1.42 |
| Debt / assetsi | 6.94 | 33.26 | 15.98 | 27.19 | 24.08 | 20.44 | 17.96 | 22.89 |
| LT debt / equityi | 10.30 | 44.11 | 24.46 | 42.31 | 38.22 | 32.53 | 33.33 | 37.32 |
| Interest coveragei | 126.40 | 158.00 | 89.14 | 32.38 | 13.05 | 15.67 | 20.57 | 24.50 |
| Revenue CAGR (3Y) %i | 13.06 | 13.91 | 16.93 | 23.33 | 23.22 | 19.13 | 13.95 | 14.29 |
| Net income CAGR (3Y) %i | 16.73 | 22.84 | 15.77 | 9.89 | 9.30 | 12.84 | 23.26 | 24.19 |
| FCF CAGR (3Y) %i | 32.24 | 18.48 | 16.27 | 19.05 | 28.10 | 14.03 | 18.45 | 21.65 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 17.84 | 20.29 | 21.99 | 23.46 | 22.50 | 23.60 |
| ROA %i | 10.18 | 11.20 | 12.41 | 13.16 | 12.08 | 12.38 |
| ROIC %i | 13.45 | 15.29 | 16.35 | 17.31 | 16.95 | 17.20 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 25.17 | 26.98 | 27.93 | 28.44 | 29.09 | 29.25 |
| FCF / sales %i | 33.56 | 32.30 | 32.69 | 33.99 | 36.87 | 40.18 |
| Current ratioi | 1.45 | 1.36 | 1.39 | 1.32 | 1.45 | 1.51 |
| Quick ratioi | 1.39 | 1.31 | 1.30 | 1.17 | 0.79 | 1.42 |
| Debt / assetsi | 19.37 | 17.96 | 20.67 | 20.09 | 17.54 | 22.89 |
| LT debt / equityi | 32.40 | 33.33 | 31.23 | 31.79 | 29.41 | 37.32 |
| Interest coveragei | 18.45 | 20.57 | 22.15 | 23.55 | 24.85 | 24.50 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Global Business Solutions is the largest reported line at 59.98% of revenue, across 2 reported segments.
- Consumer follows at 40.02%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Global Business Solutions59.98%
Consumer40.02%
Region
United States92.00%
International8.00%
Quote time 2026-10-08 07:00:00 · For reference only, not investment advice and not tailored to your situation.